4月13日 - ** 制药商ANI Pharmaceuticals ANIP.O股价盘前上涨2%至80美元
** 该公司称已推出卡巴妥（Carbatrol）的仿制药，这是一种用于治疗癫痫的药物，癫痫是一种影响大脑的发作性疾病。
** 该公司称，产品为卡马西平缓释胶囊，有100毫克、200毫克和300毫克三种剂量可供选择
** 援引 IQVIA 数据称，该品牌药物在美国的年销售额约为 6500 万美元
** 补充说，该产品的推出支持了 ANI 扩大其仿制药产品组合和改善基本药物获取的战略
** 截至上一交易日收盘，股价年累计下跌约 1%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.